Neoplasma Vol.63, No.3, p.456-461,2016
|
| Title: Treatment and prognosis of childhood acute lymphoblastic leukemia on protocols ALL-BFM 90, 95 and ALL IC-BFM 2002: a retrospective single-center study from Olomouc, Czech Republic |
| Author: J. VOLEJNIKOVA, M. JAROSOVA, D. POSPISILOVA, Z. NOVAK, J. VRBKOVA, M. HAJDUCH, V. MIHAL |
|
Abstract: Great progress has been made in the diagnostics and treatment of childhood acute lymphoblastic leukemia (ALL) over the past decades. The vast majority of children are cured, however, there is need for further improvement, especially in specific patient subgroups. Our aim was to retrospectively evaluate disease characteristics and treatment outcomes of children with ALL enrolled in a single center into consecutive treatment protocols (ALL-BFM 90, ALL-BFM 95 and ALL IC-BFM 2002) between years 1990 and 2007 and comprehensively summarize diagnostic and therapeutic advances between protocols. In total, 97 patients aged 0 to 18 years were treated for ALL at University Hospital Olomouc in the Czech Republic and steadily high relapse-free survival (RFS), event-free survival (EFS) and overall survival (OS) were observed during the evaluated time period without significant difference between the protocols (RFS 80-86%, EFS 75-83% and OS 84-92%). In conclusion, our center has demonstrated survival rates comparable to leading international study groups for childhood ALL over a substantial period of time. This has been achieved namely due to advances in diagnostics, excellent collaboration on regional, national and international level, quality assurance and high overall standard of care. The acquired experience has been crucial for current participation in the best performing Berlin-Frankfurt-Münster (BFM)-based international trials for childhood ALL.
|
|
| Keywords: acute lymphoblastic leukemia, BFM, childhood, Olomouc, prognosis |
|
|
Published online: 16-May-2016
|
| Year: 2016, Volume: 63, Issue: 3 |
Page From: 456, Page To: 461 |
doi:10.4149/316_150910N482
|
|
 download file |
|
|
|
|
